Analysis Metabolite Name Measured Value Units Genotype Sex Strain
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+3291Peak area normalizedNormal M Snell
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+4006Peak area normalizedNormal M Snell
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+4506Peak area normalizedNeg M Liver GHRKO
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+6523Peak area normalizedWT M GHRKO Global
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+6787Peak area normalizedNeg M Liver GHRKO
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+7482Peak area normalizedNeg M Liver GHRKO
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+7674Peak area normalizedWT M GHRKO Global
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+7899Peak area normalizedDwarf F Snell
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+8353Peak area normalizedNeg M Liver GHRKO
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+8460Peak area normalizedPos M Liver GHRKO
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+9053Peak area normalizedNormal F Snell
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+9172Peak area normalizedNeg M Liver GHRKO
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+9595Peak area normalizedDwarf F Snell
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+9743Peak area normalizedWT M GHRKO Global
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+9980Peak area normalizedWT M GHRKO Global
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+10270Peak area normalizedPos M Liver GHRKO
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+10561Peak area normalizedPos M Liver GHRKO
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+10953Peak area normalizedHet M PappA
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+11011Peak area normalizedKO M PappA
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+11042Peak area normalizedNormal F Snell
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+12710Peak area normalizedNeg M Liver GHRKO
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+13304Peak area normalizedPos F Liver GHRKO
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+13523Peak area normalizedWT M GHRKO Global
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+13534Peak area normalizedKO M GHRKO Global
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+14312Peak area normalizedDwarf F Snell
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+14963Peak area normalizedWT F GHRKO Global
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+15826Peak area normalizedHet M PappA
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+16349Peak area normalizedKO M PappA
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+17314Peak area normalizedPos M Liver GHRKO
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+18282Peak area normalizedWT F GHRKO Global
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+18328Peak area normalizedHet M PappA
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+18770Peak area normalizedWT F GHRKO Global
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+18810Peak area normalizedDwarf M Snell
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+18950Peak area normalizedHet M PappA
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+20096Peak area normalizedKO M GHRKO Global
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+20264Peak area normalizedKO F PappA
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+20782Peak area normalizedKO M PappA
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+21549Peak area normalizedNormal F Snell
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+22662Peak area normalizedHet F PappA
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+23100Peak area normalizedDwarf F Snell
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+23733Peak area normalizedKO F PappA
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+25082Peak area normalizedNormal F Snell
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+25487Peak area normalizedDwarf M Snell
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+25609Peak area normalizedDwarf F Snell
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+25848Peak area normalizedHet M PappA
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+26632Peak area normalizedWT F GHRKO Global
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+27062Peak area normalizedDwarf F Snell
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+27761Peak area normalizedDwarf M Snell
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+27783Peak area normalizedDwarf F Snell
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+28342Peak area normalizedKO M PappA
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+29523Peak area normalizedNormal F Snell
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+29929Peak area normalizedNeg F Liver GHRKO
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+30258Peak area normalizedWT F GHRKO Global
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+30395Peak area normalizedKO M GHRKO Global
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+31913Peak area normalizedWT F GHRKO Global
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+32272Peak area normalizedNormal F Snell
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+32752Peak area normalizedNormal F Snell
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+34169Peak area normalizedWT F GHRKO Global
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+34219Peak area normalizedNormal F Snell
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+34387Peak area normalizedHet F PappA
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+34804Peak area normalizedKO M PappA
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+35470Peak area normalizedDwarf F Snell
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+36237Peak area normalizedKO M PappA
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+36607Peak area normalizedNeg F Liver GHRKO
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+37101Peak area normalizedKO F GHRKO Global
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+37797Peak area normalizedDwarf M Snell
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+39309Peak area normalizedHet F PappA
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+40404Peak area normalizedKO F GHRKO Global
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+40789Peak area normalizedKO F PappA
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+40875Peak area normalizedKO F GHRKO Global
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+43472Peak area normalizedHet F PappA
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+43672Peak area normalizedHet F PappA
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+44280Peak area normalizedNeg F Liver GHRKO
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+46501Peak area normalizedKO F PappA
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+46999Peak area normalizedPos M Liver GHRKO
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+51977Peak area normalizedDwarf M Snell
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+52840Peak area normalizedKO M GHRKO Global
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+55615Peak area normalizedKO F GHRKO Global
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+55823Peak area normalizedPos F Liver GHRKO
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+57236Peak area normalizedNeg F Liver GHRKO
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+62431Peak area normalizedKO F PappA
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+62999Peak area normalizedKO F PappA
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+63014Peak area normalizedKO F PappA
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+67262Peak area normalizedKO F GHRKO Global
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+75557Peak area normalizedPos F Liver GHRKO
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+79539Peak area normalizedKO F PappA
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+82368Peak area normalizedKO M GHRKO Global
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+84751Peak area normalizedKO M GHRKO Global
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+95639Peak area normalizedHet M PappA
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+97854Peak area normalizedDwarf M Snell
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+107630Peak area normalizedPos F Liver GHRKO
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+131831Peak area normalizedHet F PappA
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+140954Peak area normalizedNeg F Liver GHRKO
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+160971Peak area normalizedWT F GHRKO Global
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+182568Peak area normalizedHet F PappA
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+191540Peak area normalizedPos F Liver GHRKO
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+195603Peak area normalizedNeg F Liver GHRKO
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+229802Peak area normalizedKO F GHRKO Global
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+241997Peak area normalizedPos F Liver GHRKO
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+250315Peak area normalizedKO F GHRKO Global
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+351652Peak area normalizedNeg F Liver GHRKO
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+443133Peak area normalizedPos F Liver GHRKO
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+462983Peak area normalizedNeg F Liver GHRKO
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+589786Peak area normalizedKO F GHRKO Global
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+Peak area normalizedHet F PappA
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+Peak area normalizedNormal M Snell
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+Peak area normalizedPos F Liver GHRKO
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+Peak area normalizedPos M Liver GHRKO
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+Peak area normalizedWT M GHRKO Global

Return to search page
  logo